Hospitals worldwide are working on minimizing unnecessary use of antimicrobials. To assess actual changes of antimicrobial usage, correct and precise measurements are necessary. This study aimed to compare data on the purchase of antibiotics from the pharmacy and the administration of antibiotics to patients, respectively, in an intensive care unit (ICU). Data were obtained from the Neurointensive Care Unit (NICU) at Rigshospitalet, Denmark. During a 23-month period, comprising 10 770 bed-days (BD), the ward purchased 16 908 defined daily doses (DDD) of antibiotics from the pharmacy, and 15 130 DDD and 41 304 individual doses were administered. Intraclass correlation coefficients (ICCs) were calculated; control and runcharts and a Bland-Altman plot were constructed. Pharmacy sales and drug administration data showed no systematic variation over time with a monthly overestimation of pharmacy sales data of 10% (95% confidence interval (CI), 6.20-14.3%) for all antibiotics, and 7% (95% CI: 1.81-11.1%) for broad-spectrum antibiotics. The antibiotic consumption, without bed-days, has a clinically acceptable ICC of >0.70 and no systematic difference is suggested by the Bland-Altman plot. In this study of a large NICU, whose antibiotic consumption varied at random, pharmacy sales data were an acceptable approximation of the actual summarized drug consumption.
The worldwide consumption of antimicrobials has increased during the last 15 years (1) , and several studies in the same period have shown a positive correlation between antimicrobial consumption and development of drug-resistant bacteria (2-7). Infections caused by multi-or extremely drug-resistant (MDR or XDR) bacteria may result in increased morbidity, mortality, and healthcare costs (8) (9) (10) (11) (12) . In an intensive care unit (ICU), consideration about using broad-spectrum antimicrobials and a risk of inducing resistance should be balanced against that delayed antimicrobial therapy to patients with severe infection may be associated with an increased mortality (13, 14) .
Hospitals around the world have attempted to reduce their antimicrobial consumption, and the strategies on how to implement this reduction vary greatly. Some hospitals educate staff on the risks of antimicrobial misuse; some others perform audits on doctors' prescriptions, either on computers using specialized programs or by conducting manual audits by qualified personnel; and yet, others simply prohibit the use of certain antimicrobials (5, (15) (16) (17) .
In addition to the variation in strategies to reduce the consumption of antimicrobials, variable methods are used to monitor antibiotic consumption. The World Health Organization (WHO) recommends using the number of defined daily doses (DDD) per 100 bed-days (BD) (18) . However, the numerator and denominator differ between studies.
Even though the WHO has recommended a standard unit, several studies use alternatives such as Days of Therapy (DOT) (19, 20) , prescribed daily doses (PDD) (21, 22) , or antibiotic-free days (23) (24) (25) . Not only does the numerator differ in the recommended measurement of DDD per 100 BD, but also the denominator, which can vary between 100 and 1000 BD. Even the number of admissions is sometimes used as a denominator (21, 26) . The term BD has not been clearly defined either, for example whether the day of admission and/or discharge is counted or not. A systematic comparison between studies is difficult, due to this lack of consistency (21, 26) .
Furthermore, various methods are used in different studies for collecting the consumption data. The easiest, most popular, and cheapest method to acquire data on antimicrobial consumption is to obtain data on purchased antimicrobials from the supplying pharmacy. Pharmacy sales data, however, do not take into account whether or not the patients have actually received the drugs, and whether or not this consumption takes place during the hospitalization (27, 28) . Other means to acquire and collect consumption data include counting the ward stock, studying the prescriptions from the doctors' charts, or noting down antibiotic administrations from the nurses' charts (27, 29) , but these measures are more labor-intensive and furthermore require access to individual personal data. Validated methods to calculate the antibiotic consumption on a defined time scale are extremely important when interventions in antibiotic use are contemplated.
In the present study, we compared the antibiotic consumption as measured by pharmacy sales data to that measured by registering drug administration to individual patients in a large ICU. We hypothesized that the pharmacy sales data were an acceptable approximation of administration data.
MATERIALS AND METHODS

Setting
According to the Danish law, this retrospective database study was approved by the Danish Data Protection Agency and the head of the Department of Neuroanaesthesiology, upon correspondence (3-3013-996/1/) with the Danish Board of Health.
Rigshospitalet (RH), University of Copenhagen, is a public, tertiary, 1100-bed university hospital in the Capital Region of Denmark. The 20-bed Neurointensive Care Unit (NICU), 1 which was selected for this study, is a part of the Department of Neuroanaesthesiology and has patients admitted with neurological or neurosurgical diagnoses that require a highly specialized intensive care. The NICU purchases its antimicrobials from the Pharmacy of the Capital Region of Denmark on a day-to-day basis and stores them in a purpose-built, locked room inside the department until administered to patients. The Pharmacy of the Capital Region of Denmark provides medicines for all departments at the RH based on an electronic ordering system (ApoVision, Navtilus, Aalborg, Denmark). Pharmacists and pharmacists' assistants appointed by the Pharmacy and affiliated with the NICU oversee the drug purchases and match the purchase to demands daily on workdays.
All drugs are prescribed, dispensed, and administered to the patient in a rigorously controlled process, which is regulated by a set of guidelines issued by the Capital Region. In the study period, prescriptions of drugs to NICU patients are registered by the attending physicians in a patient data management system designed for ICUs, the Critical Information System (CIS, Daintel, Copenhagen, Denmark). The information on medications includes indication, dosage, frequency, and route of administration. Individual drug dispensations and administrations are then recorded by nurses in the same system.
Design
This study compared the following two data types: pharmacy sales data (sales data) and individual patient data on drug administration (administration data). Sales data on the purchase of antimicrobials by the NICU from the Pharmacy of the Capital Region of Denmark from February 1, 2012 through December 31, 2013 (23 months) were extracted from ApoVision. Administration data on individual drug administration for patients admitted in the same period were extracted from the CIS.
Sales and administration data were extracted using a Structured Query Language (SQL)-query and entered into an Excel spreadsheet, from which they were transferred to the statistical software, RStudio version 0.98.1091 (RStudio Team (2015) . RStudio: Integrated Development for R. RStudio, Inc., Boston, MA URL). (Fig. 1) .
For both datasets, antimicrobials were classified by Anatomical Therapeutic Chemical Classification System (ATC) level 5. Only drugs in ATC group J01, antibacterials for systemic use, were analyzed in the present study. Drug doses were converted into defined daily doses (DDD) according to standards issued by the WHO (18) . Antibiotic use was calculated for all and for broad-spectrum antibiotics, respectively; the latter group was defined according to the traditional guidelines issued by the Danish Statens Serum Institut (SSI) (see list in Appendix 1). Antibiotic consumption was normalized to bed-days (DDD per 100 BD) as recommended by the WHO in order to control for variation in bed occupancy ratios (18) . Both admission and discharge days were included. Data were summarized monthly throughout the study period.
Statistical analysis
All analyses were performed in R (R 2. known as 'common cause' variation) was evaluated by constructing control charts. Alignment of the two different methods, that is pharmacy sales data and individual administration data, was evaluated by constructing runcharts. The use of intra-class correlation coefficients (ICCs) is recommended by Hripcsak and Heitjan (30) as the best coefficient for description of the characteristics of correlation, instead of the more widely utilized Pearson's correlation coefficient. This study focused on different types of ICCs to find the consistency and agreement between our measuring methods. ICC(3,1) were calculated as a measure of consistency and ICC(2,1) were calculated for agreement. If two methods align, the ICCs for both consistency and agreement coefficient are 1. Conversely, if one of the methods of measuring yields consistently larger values than the other, but the values are otherwise aligned, the agreement coefficient will be below 1, whereas the consistency coefficient remains 1 (31) . For the present study, an ICC ≥ 0.70 was considered to be clinically acceptable. Finally, Bland-Altman plots were constructed to compare the performance of the two methods quantitatively.
This study made use of a Bland-Altman plot, because it helps to analyze the usability of the different methods of measuring antibiotic consumption. The Bland-Altman plot, first described in a medical context in 1986, is used to compare two measuring techniques to tell us, if they agree and correlate sufficiently (32) . An agreement in a Bland-Altman plot requires that the two methods of measuring generate the same number. If the two methods are aligned, but one of them is larger than the other, then the measurements do not agree, but can possibly correlate (33) .
RESULTS
During the study period of 23 months (from February 1, 2012 to December 31, 2013), 1565 patients were admitted, corresponding to a total of 10 770 bed-days. The average length of stay was 6.89 days. According to the patient-specific data obtained from the CIS, 15 130 DDD of antibiotics were administered during a total of 41 304 administrations; according to the sales data obtained from ApoVision, 16 908 DDD were acquired from the pharmacy. Thus, a total of 1778 DDD were purchased from the pharmacy, but were not registered as administered to individual patients, Table 1 . According to administration data, broad-spectrum antibiotics comprised 85.1% of the total consumption of antibiotics.
The consumption over time of all antibiotics and of broad-spectrum antibiotics, respectively, showed Fig. 1 . Extraction of data from the Neurointensive care unit (NICU). Bed-days, prescription, and administration data are extracted from critical information system Critical Information Service (CIS) as a cumulative number and pharmacy sales data from ApoVision. Data from ApoVision are exported into an Excel sheet, which is imported into R, whereas the CIS data are extracted directly by R using a Structured Query Language (SQL) call. R is used to create the desired output. A systematic difference between pharmacy sales and administration data of 77 DDD/month for all antibiotics and of 43 DDD/month for broad-spectrum antibiotics was found. DDD, defined daily dose; BD, bed-days; PSD: pharmacy sales data; AD: Administration; CI: confidence interval.
no systematic variation from the mean, indicating a common cause of variation over time for both administration and pharmacy sales data (Figs 2A  and 3A) . The Bland-Altman plot showed no systematic difference between the two types of measurements ( Figs 2B and 3B ). For the consumption of all antibiotics with no correction for bed-days, the ICC for both agreement and consistency was ≥0.70, whereas correction for bed-days led to a marked decline in ICC agreement (Table 2) , due to proportionally larger mean differences. Similarly, the ICC for broad-spectrum antibiotic consumptions without correction for bed-days was ≥0.70 for both consistency and agreement; with correction for bed-days, both measurements declined markedly. The relative difference between pharmacy sales and administration data per month was 10% (95% confidence interval (CI): 6.2-14.3%) for all antibiotics and 7% (CI: 1.8-11.1%) for broad-spectrum antibiotics. The Bland-Altman plot showing antibiotic consumption with the antibiotics categorized in ATC5 (Fig. 4A ) displayed a trumpet shape, indicating that when the consumption of a specific antibiotic increased, the difference between pharmacy sales data and administration data increased as well. If the mean is filtered so that only data with a mean DDD per 100 BD per month > 10 are included, Fig. 4B , the trumpet form disappears. The corresponding ICC for agreement was 0.91 and for consistency was 0.91.
DISCUSSION
The most accurate method for the measurement of antimicrobial consumption is usually by obtaining administration data. Administration data are the nearest approximation of the actual consumption, even though intermittent system breakdowns and a high clinical workload might result in lack of registration of the administered antibiotic. Administration data are often harder to acquire than the sales data as they are embedded in clinical patient management systems and are linked to privileged (personal) data. In contrast, pharmacy sales data are often easier to access because they are extracted from invoices for the purchased medication and do not link to personal data. Therefore, sales data are often used as an indicator of antimicrobial consumption, instead of the more accurate administration data. According to the present study, it is possible to use sales data as an approximation of the actual antibiotic consumption with certain reservations. Thus, the sales data were an acceptable approximation of the actual consumption of all antibiotics in total when they were not corrected for bed days. On average, sales data were around 10% higher than the actual consumption. The difference was relatively consistent, with ICC for both agreement and consistency of ≥0.70, the usually accepted limit for clinical purposes. Considering broad-spectrum antibiotics, the results were approximately the same, with a mean difference of around 7% and with clinically acceptable ICCs when data were not corrected for bed-days.
The present study used the standard unit of measurement of antimicrobial consumption in hospitals, recommended by the WHO, which is Defined Daily Dose (DDD) per 100 bed-days (BD). DDD is defined as the maintenance dosage for the specific drug when using it for its primary indication (18) .
When antibiotics were grouped by ATC5 level, the more rarely used antibiotics (those with a mean consumption <10 DDD/100BD/month) showed an increasing difference, as the mean consumption increased. Thus, it would not be possible to use pharmacy sales data for these drugs individually. However, for the more frequently used drugs the Bland-Altman plot and ICC indicate that the pharmacy sales data may be used as an approximation.
This study used data from a highly specialized NICU, in which the variation in antibiotic consumption was due to a common cause, that is, did not deviate systematically from the mean over time. From the present data, it is not possible to predict whether pharmacy sales data will change if antibiotic consumption changes, for example by a change in the politics of antibiotic use in the unit. However, the ICC consistency indicates that sales data will likely change in the same direction. Fig. 3 . Neuro intensive care unit (NICU) antibiotic consumption, broad-spectrum. Antibiotic consumption data for broad spectrum antibiotics in the Neurointensive Care Unit NICU. Runcharts (with corresponding control chart, not shown) (A) for pharmacy sales data and administration data, respectively, both show no systematic deviation from the mean, indicating a random variation (common cause). Pearson's correlation coefficient was calculated (r = 0.70). The broken lines represent the corresponding means. The Bland-Altman plot (B) shows no systematic variation. The mean difference is demonstrated by the middle dotted line, whereas the two other dotted lines represent the 95% confidence intervals (CI).
Solano & Matthews (29) have previously compared the pharmacy's dispensing data with administration data for all antibiotics in an Australian ICU, where the pharmacy dispensed the prescribed drugs in aliquots that corresponded to the dose administered. Even though the route of drugs from pharmacy to the patients appeared to be shorter than in our setting, this report showed only a weak correlation between pharmacy data and administration data over a 21-month period, as compared by Pearson's correlation coefficient. Another study published in 2005 (28) compared dispensation and administration data in both medical and surgical ICUs and non-ICUs in a 550-bed hospital in the USA. This cross-sectional study randomly selected 463 antibiotic doses and found that at least 40% of parenteral antimicrobial doses dispensed from the pharmacy were not administered. Indeed, a substantial and variable proportion -between 1% and 20% -of medication doses dispensed from hospital pharmacies were wasted or returned unused. Finally, Haug et al. (27) compared a weekly ward stock count with pharmacy sales in a 350-bed tertiary hospital over a period of 26 weeks in 2007. This relatively large study concluded that pharmacy data can be used if accumulated for periods no shorter than 4 weeks when considering parenteral formulations, whereas a much longer period must be used for oral medications. The study recommended that the consumption of antibiotics should be measured by counting the ward stock. However, no attempt was made to measure the actual consumption by administration data.
Many factors play a role in the difference between sales data and administration data. One of them is the transfer of patients between wards. Sometimes medications may have been purchased by the old ward, but administered in the new ward. This source of error was minimized in the present study, because the ApoVision system lets nurses record which medications have traveled between wards. Also, outdated medications that are discarded are especially important in wards where the antimicrobial consumption is low, and the types of stocked antimicrobials vary. This factor was minimized in the present ICUs, which had a high turnover of antibiotics. In contrast, parenterally administered drugs may only be used within a narrow time frame, increasing the risk that excess or outdated drugs are discarded. Since most antimicrobials in an ICU are administered parenterally, this error source may have had a large impact. Moreover, drug containers may change in size over time or between specific drugs, leading to a change in the amount of discarded drugs; thus, an alteration of antibiotic recommendations may change the pharmacy sales data, even though the total DDD remains unchanged.
The difference between sales and administration data is lower when analyzing broad spectrum antibiotics, which might be because of the proportionally high usage of 85%. The reasons, as described above, might be a lower amount of the discarded parenterally drugs and a lower risk of having drugs which exceeds the expiration date.
Our study is limited to concluding that the monthly pharmacy sales data could be used as an approximation for consumption in the specific NICU during a period where the choice of antibiotics is stable and the total consumption relatively high. The results should be interpreted with caution when considering ICUs caring for patients from other medical specialties, with fewer beds, a lower or unstable antibiotic consumption rate, less parenterally administered medicine, or with different procedures for drug ordering, dispensation, or administration. However, hopefully this study may serve as a template to acquire the same information about other wards. As a reference, we believe individual administration data remain the most accurate data of antibiotic consumption in most wards.
CONCLUSION
This study compared the antibiotic consumption as measured by monthly sales data from the supplying pharmacy to consumption as measured by individual administration in an NICU during a 23-month period. Pharmacy sales data were an acceptable approximation of the total antibiotic consumption in the selected ward, with a consistent overestimation of around 10% compared to administration data. The pharmacy sales data were also usable as an approximation of the consumption of broadspectrum antibiotics; however, pharmacy sales data of specific antibiotics by ATC level 5 did not render a sufficiently accurate approximation of individual administration data.
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